- Home
- DHT vs SRPT Comparison
DHT vs SRPT Comparison
Compare DHT & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHT
- SRPT
- Stock Information
- Founded
- DHT 2005
- SRPT 1980
- Country
- DHT Bermuda
- SRPT United States
- Employees
- DHT N/A
- SRPT N/A
- Industry
- DHT Marine Transportation
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- DHT Consumer Discretionary
- SRPT Health Care
- Exchange
- DHT Nasdaq
- SRPT Nasdaq
- Market Cap
- DHT 1.7B
- SRPT 1.9B
- IPO Year
- DHT 2005
- SRPT 1997
- Fundamental
- Price
- DHT $11.49
- SRPT $22.90
- Analyst Decision
- DHT Strong Buy
- SRPT Hold
- Analyst Count
- DHT 4
- SRPT 31
- Target Price
- DHT $13.75
- SRPT $40.61
- AVG Volume (30 Days)
- DHT 1.7M
- SRPT 6.5M
- Earning Date
- DHT 11-11-2025
- SRPT 11-05-2025
- Dividend Yield
- DHT 8.29%
- SRPT N/A
- EPS Growth
- DHT 19.95
- SRPT N/A
- EPS
- DHT 1.17
- SRPT N/A
- Revenue
- DHT $557,643,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- DHT N/A
- SRPT $9.41
- Revenue Next Year
- DHT $32.35
- SRPT N/A
- P/E Ratio
- DHT $9.79
- SRPT N/A
- Revenue Growth
- DHT N/A
- SRPT 64.89
- 52 Week Low
- DHT $8.67
- SRPT $10.42
- 52 Week High
- DHT $13.06
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- DHT 40.09
- SRPT 71.18
- Support Level
- DHT $11.27
- SRPT $17.57
- Resistance Level
- DHT $11.93
- SRPT $23.42
- Average True Range (ATR)
- DHT 0.25
- SRPT 1.36
- MACD
- DHT -0.15
- SRPT 0.61
- Stochastic Oscillator
- DHT 13.18
- SRPT 77.97
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. The group generates revenues from time charter and spot market operations. It operates through integrated management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from the shipping revenues.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.